Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044265
Filing Date
2024-11-08
Accepted
2024-11-08 16:05:54
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 884580
2 ex3-1.htm EX-3.1 582984
3 ex31-1.htm EX-31.1 11895
4 ex31-2.htm EX-31.2 11935
5 ex32-1.htm EX-32.1 4490
6 ex32-2.htm EX-32.2 4315
  Complete submission text file 0001493152-24-044265.txt   5466656

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE idxg-20240930.xsd EX-101.SCH 35108
8 XBRL CALCULATION FILE idxg-20240930_cal.xml EX-101.CAL 61694
9 XBRL DEFINITION FILE idxg-20240930_def.xml EX-101.DEF 126864
10 XBRL LABEL FILE idxg-20240930_lab.xml EX-101.LAB 286817
11 XBRL PRESENTATION FILE idxg-20240930_pre.xml EX-101.PRE 239507
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 685256
Mailing Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054
Business Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

EIN.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24249 | Film No.: 241440517
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)